Multiple Sclerosis Clinical Trial
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
Summary
This study is a two-part trial consisting of Part A (presented in this record) and Part B (see NCT02047734).
The primary objective in Part A of this study was to demonstrate the superior efficacy of ozanimod compared to placebo by showing a reduction in the cumulative number of total gadolinium-enhancing (GdE) lesions from Week 12 to Week 24 in patients with relapsing multiple sclerosis (RMS).
Eligibility Criteria
Inclusion Criteria:
Multiple sclerosis as diagnosed by the revised 2010 McDonald criteria
Expanded Disability Status Scale (EDSS) score between 0 and 5.0 at Baseline
Exclusion Criteria:
Secondary or primary progressive multiple sclerosis
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 56 Locations for this study
Berkeley California, 94705, United States
Fresno California, 93710, United States
Sacramento California, 95817, United States
Charlotte North Carolina, 28204, United States
Akron Ohio, 44320, United States
Seattle Washington, 98104, United States
Brussels , 1200, Belgium
Montegnee , 4420, Belgium
Ottignies , 1340, Belgium
Sofia , 1431, Bulgaria
Tbilisi , 0112, Georgia
Tbilisi , 0160, Georgia
Tbilisi , 0179, Georgia
Athens , 10676, Greece
Athens , 11525, Greece
Thessaloniki , 57010, Greece
Esztergom , 2500, Hungary
Cantania , 95123, Italy
Czeladz , 41-25, Poland
Grudziadz , 86-30, Poland
Katowice , 40-65, Poland
Katowice , 40-74, Poland
Katowice , 40-75, Poland
Kielce , 25-72, Poland
Konstancin Jeziorna , 05-51, Poland
Lublin , 20-71, Poland
Lódzkie , 90-32, Poland
Olsztyn , 10-56, Poland
Plewiska , 62-06, Poland
Podlaskie , 15-40, Poland
Poznan , 61-85, Poland
Szczecin , 70-11, Poland
Warminsko-mazurskie , 10-44, Poland
Warsaw , 00-73, Poland
Warsaw , 02-50, Poland
Warszawa , 00-90, Poland
Warszawa , 02-95, Poland
Campulung , 11510, Romania
Cluj-Napoca , 40034, Romania
Napoca , 40000, Romania
Timisoara , 30073, Romania
Kazan , 42002, Russian Federation
Kazan , 42009, Russian Federation
Saransk , 43003, Russian Federation
Belgrade , 11000, Serbia
Belgrade , 11000, Serbia
Belgrade , 11000, Serbia
Belgrade , 11080, Serbia
Kragujevac , 34000, Serbia
San Sebastian , 20014, Spain
Valencia , 46026, Spain
Chernigiv , 14033, Ukraine
Dnipropetrovsk , 49027, Ukraine
Ivano Frankivsk , 76008, Ukraine
Kharkiv , 61103, Ukraine
Kyiv , 04107, Ukraine
Lutsk , 43024, Ukraine
Vinnytsya , 21005, Ukraine
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.